Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: synthesis, structure-affinity relationships and molecular modeling studies

Bioorg Med Chem. 2013 Jan 1;21(1):283-94. doi: 10.1016/j.bmc.2012.10.031. Epub 2012 Oct 29.

Abstract

A number of 5-oxo-pyrazolo[1,5-c]quinazolines (series B-1), bearing at position-2 the claimed (hetero)aryl moiety (compounds 1-8) but also a carboxylate group (9-14), were designed as hA(3) AR antagonists. This study produced some interesting compounds endowed with good hA(3) receptor affinity and high selectivity, being totally inactive at all the other AR subtypes. In contrast, the corresponding 5-ammino derivatives (series B-2) do not bind or bind with very low affinity at the hA(3) AR, the only exception being the 5-N-benzoyl compound 19 that shows a hA(3)K(i) value in the high μ-molar range. Evaluation of the synthetic intermediates led to the identification of some 5(3)-(2-aminophenyl)-3(5)-(hetero)arylpyrazoles 20-24 with modest affinity but high selectivity toward the hA(3) AR subtype. Molecular docking of the herein reported tricyclic and simplified derivatives was carried out to depict their hypothetical binding mode to our model of hA(3) receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells
  • Cricetinae
  • Humans
  • Molecular Dynamics Simulation
  • Purinergic P1 Receptor Antagonists / chemistry*
  • Purinergic P1 Receptor Antagonists / pharmacology*
  • Pyrazoles / chemistry*
  • Pyrazoles / pharmacology*
  • Quinazolines / chemistry*
  • Quinazolines / pharmacology*
  • Receptor, Adenosine A3 / metabolism*
  • Structure-Activity Relationship

Substances

  • Purinergic P1 Receptor Antagonists
  • Pyrazoles
  • Quinazolines
  • Receptor, Adenosine A3